CZ20011434A3 - Částice potažené granulovaným krystalickým ibuprofenem - Google Patents

Částice potažené granulovaným krystalickým ibuprofenem

Info

Publication number
CZ20011434A3
CZ20011434A3 CZ20011434A CZ20011434A CZ20011434A3 CZ 20011434 A3 CZ20011434 A3 CZ 20011434A3 CZ 20011434 A CZ20011434 A CZ 20011434A CZ 20011434 A CZ20011434 A CZ 20011434A CZ 20011434 A3 CZ20011434 A3 CZ 20011434A3
Authority
CZ
Czechia
Prior art keywords
ibuprofen
ethylcellulose
weight
relative
particles
Prior art date
Application number
CZ20011434A
Other languages
English (en)
Other versions
CZ292290B6 (cs
Inventor
Jean-Marc Zuccarelli
Charles Chauveau
Gilles Demichelis
Karine Jean
Original Assignee
Laboratoires Des Produits Ethiques Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Des Produits Ethiques Ethypharm Sa filed Critical Laboratoires Des Produits Ethiques Ethypharm Sa
Publication of CZ20011434A3 publication Critical patent/CZ20011434A3/cs
Publication of CZ292290B6 publication Critical patent/CZ292290B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
CZ20011434A 1998-11-06 1999-11-03 Částice potažené granulovaným krystalickým ibuprofenem CZ292290B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9814033A FR2785539B1 (fr) 1998-11-06 1998-11-06 Particules enrobees d'ibuprofene cristallin granule

Publications (2)

Publication Number Publication Date
CZ20011434A3 true CZ20011434A3 (cs) 2001-09-12
CZ292290B6 CZ292290B6 (cs) 2003-08-13

Family

ID=9532492

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011434A CZ292290B6 (cs) 1998-11-06 1999-11-03 Částice potažené granulovaným krystalickým ibuprofenem

Country Status (26)

Country Link
US (1) US6951657B1 (cs)
EP (1) EP1126829B1 (cs)
JP (1) JP3987282B2 (cs)
KR (1) KR100586059B1 (cs)
CN (1) CN1154482C (cs)
AT (1) ATE265206T1 (cs)
AU (1) AU765765B2 (cs)
BR (1) BR9915111A (cs)
CA (1) CA2349503C (cs)
CZ (1) CZ292290B6 (cs)
DE (1) DE69916876T2 (cs)
DK (1) DK1126829T3 (cs)
EA (1) EA002897B1 (cs)
ES (1) ES2219073T3 (cs)
FR (1) FR2785539B1 (cs)
HK (1) HK1039890B (cs)
HU (1) HU229936B1 (cs)
IL (1) IL142787A (cs)
MX (1) MXPA01004517A (cs)
NZ (1) NZ511479A (cs)
PL (1) PL194527B1 (cs)
PT (1) PT1126829E (cs)
SK (1) SK283944B6 (cs)
TR (1) TR200101230T2 (cs)
WO (1) WO2000027368A1 (cs)
ZA (1) ZA200103630B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
FR2824477B1 (fr) * 2001-05-09 2005-09-09 Ethypharm Lab Prod Ethiques Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
BRPI0609448A2 (pt) * 2005-03-22 2010-04-06 Losan Pharma Gmbh ibuprofeno solubilizado
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
CA2615496C (en) * 2005-07-18 2014-11-18 Horizon Therapeutics, Inc. Medicaments containing famotidine and ibuprofen and administration of same
US8067451B2 (en) * 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
DE102005049001A1 (de) * 2005-10-11 2007-04-12 Basf Ag Verfahren zur Herstellung von direkttablettierbaren Ibuprofen-Formulierungen
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
AU2007279036A1 (en) * 2006-07-27 2008-01-31 University Of Sunderland Coating composition comprising starch
TWI564008B (zh) 2010-09-30 2017-01-01 鹽野義製藥股份有限公司 難溶性藥物之溶解性改善製劑
WO2014198999A1 (en) * 2013-06-13 2014-12-18 Opes Corporation Oy Matrix
US9474699B2 (en) * 2014-03-31 2016-10-25 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of a basic benefit agent
WO2016081783A1 (en) * 2014-11-19 2016-05-26 Kiromic, Llc Novel nanoparticle-based vaccine targeting cancer/testis antigens (cta) and its use in solid and hematological malignancies
US20200360335A1 (en) 2017-10-26 2020-11-19 Zhejiang Yuejia Pharmaceuticals Co., Ltd Stable pharmaceutical composition containing non-steroidal anti-inflammatory drug derivative
AU2020225448B2 (en) 2019-02-22 2025-09-18 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
KR20210129649A (ko) * 2019-02-22 2021-10-28 카탈렌트 유.케이. 스윈던 지디스 리미티드 이부프로펜을 포함하는 약학적 조성물의 응집, 에어레이션 최소화 및 코팅 보존
MX2021009844A (es) 2019-02-22 2021-09-10 Catalent Uk Swindon Zydis Ltd Conservacion de particulas de ingredientes farmaceuticos activos revestidas funcionalmente producidas mediante procesos de mezcla sin solvente en suspension acuosa.
PL3927322T3 (pl) 2019-02-22 2024-02-05 Catalent U.K. Swindon Zydis Limited Minimalizacja napowietrzania zawiesin podczas mieszania typu in-line
BR112023001716A2 (pt) 2020-07-31 2023-04-04 Catalent Uk Swindon Zydis Ltd Composições farmacêuticas compreendendo api revestido

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
US4588612A (en) * 1985-04-24 1986-05-13 Scm Corporation Pretreatment in encapsulation process
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
US4835186A (en) 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
NZ234587A (en) * 1989-08-04 1991-11-26 Mcneil Ppc Inc A chewable pharmaceutical tablet of compressed coated granules
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
FI924589L (fi) * 1990-04-11 1992-10-09 Upjohn Co Smakmaskering av ibuprofen med virvelbaeddbetaeckning
FR2679451B1 (fr) * 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
US5191114A (en) * 1991-10-09 1993-03-02 Sage Pharmaceuticals, Inc. Process for enhancing the flow characteristics of ibuprofen
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)

Also Published As

Publication number Publication date
HUP0104394A3 (en) 2002-12-28
HU229936B1 (en) 2015-01-28
AU1050800A (en) 2000-05-29
SK5662001A3 (en) 2001-11-06
AU765765B2 (en) 2003-09-25
NZ511479A (en) 2003-02-28
EP1126829A1 (fr) 2001-08-29
KR100586059B1 (ko) 2006-06-07
ATE265206T1 (de) 2004-05-15
MXPA01004517A (es) 2003-06-09
HK1039890B (zh) 2005-01-07
BR9915111A (pt) 2001-11-27
CA2349503A1 (fr) 2000-05-18
DE69916876T2 (de) 2005-03-31
DE69916876D1 (de) 2004-06-03
JP2002529399A (ja) 2002-09-10
KR20010090830A (ko) 2001-10-19
CZ292290B6 (cs) 2003-08-13
IL142787A (en) 2007-06-03
CA2349503C (fr) 2010-07-13
PT1126829E (pt) 2004-08-31
EA002897B1 (ru) 2002-10-31
EA200100491A1 (ru) 2001-12-24
FR2785539B1 (fr) 2004-04-09
US6951657B1 (en) 2005-10-04
EP1126829B1 (fr) 2004-04-28
PL194527B1 (pl) 2007-06-29
ES2219073T3 (es) 2004-11-16
CN1328450A (zh) 2001-12-26
FR2785539A1 (fr) 2000-05-12
SK283944B6 (sk) 2004-05-04
WO2000027368A1 (fr) 2000-05-18
CN1154482C (zh) 2004-06-23
DK1126829T3 (da) 2004-08-09
JP3987282B2 (ja) 2007-10-03
TR200101230T2 (tr) 2001-10-22
HK1039890A1 (en) 2002-05-17
ZA200103630B (en) 2002-05-06
HUP0104394A2 (hu) 2002-03-28
PL347549A1 (en) 2002-04-08

Similar Documents

Publication Publication Date Title
PL347549A1 (en) Particles coated with granulated crystalline ibuprofen
ES2125099T3 (es) Composiciones que comprenden nanoparticulas de un antiinflamatorio no estereoideo.
EP0711152A4 (en) ORAL DOSAGE FORMS WITH POWDER LAYER
AU6517496A (en) Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
PH22003A (en) Pharmaceutical formulation
ES2107685T3 (es) Composiciones de ranitidina que enmascaran su sabor.
CA2407072A1 (en) Taste masking coating composition
MX9605650A (es) Formulaciones de propionato de fluticasona.
CA2215329A1 (en) Colorectal chemoprotective composition and method for preventing colorectal cancer
JPS55153715A (en) Prolonged granule of theophylline
AU7921887A (en) Therapeutic agents
GR3030084T3 (en) Sprayable film forming system releasing active substances for use on plants
SG46307A1 (en) New pyrazine derivatives the preparation and use thereof
AU3537893A (en) Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use
CA2126699A1 (en) An Iron-Containing Composition for the Prevention of Anaemia and a Method for Producing the Composition
ES2132122T3 (es) Procedimiento para la preparacion de composiciones polimericas.
JPS5714589A (en) Benzothiazine derivative, its preparation and drug composition
MX9803918A (es) Tabletas de liberacion rapida comprendiendo acido tolfenamico o una sal farmaceuticamente aceptable del mismo como ingrediente activo y un metodo para la preparacion de dicha tableta.
DE3474024D1 (en) Contraceptive compositions based on esters of levo-norgestrel
CA2314122A1 (en) Sweetener composition
GB9303132D0 (en) Modified release formulation
JPS5521733A (en) Production of antibiotic y-12278 and carcinostatic preparation containing the same as the effective ingredient
AP2002002662A0 (en) Sertraline salts and sustained-release dosage forms of sertraline
MXPA04002324A (es) Aminas como agentes anti-alcoholismo.
SI9200167B (sl) Veterinarmedicinski preparat kot dodatek pitni vodi ali živalski hrani, ki vsebuje antibiotično mešanico gentamicina in linkomicina, ter njegova uporaba v prašičjereji.

Legal Events

Date Code Title Description
MK4A Patent expired

Effective date: 20191103